Your new post is loading...
Israeli scientists say a new study has shown that a small molecule called PJ34 has triggered the self-destruction of human pancreatic cancer cells in mice. According to the research, published in the peer-reviewed open-access biomedical journal Oncotarget, the administration of the molecule reduced the number of cancer cells in developed tumors by up to 90 percent in 30 days.
The study was led by Professor Malka Cohen-Armon and her team at Tel Aviv University’s Sackler Faculty of Medicine, in collaboration with Dr. Talia Golan and her team at the Cancer Research Center at Sheba Medical Center, and conducted with transplantations of human pancreatic cancer cells into immunocompromised mice, or xenografts.
Learn more / En savoir plus / Mehr erfahren:
https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer
Israeli scientists say a new study has shown that a small molecule called PJ34 has triggered the self-destruction of human pancreatic cancer cells in mice. According to the research, published in the peer-reviewed open-access biomedical journal Oncotarget, the administration of the molecule reduced the number of cancer cells in developed tumors by up to 90 percent in 30 days.
The study was led by Professor Malka Cohen-Armon and her team at Tel Aviv University’s Sackler Faculty of Medicine, in collaboration with Dr. Talia Golan and her team at the Cancer Research Center at Sheba Medical Center, and conducted with transplantations of human pancreatic cancer cells into immunocompromised mice, or xenografts.
Learn more / En savoir plus / Mehr erfahren:
https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer